SmartAnalyst provides strategic consulting and analytics services to bio-pharma companies. In support of our clients’ efforts to identify and commercialize novel innovative therapies to improve patient outcomes and garner market success, we support their strategic decisions at the Disease Area, Asset and Portfolio levels. Additionally, we partner with Value teams, by providing Health Economics and Outcomes Research Services, including analysis and delivery of Real-World Evidence studies. Lastly, we provide Insights, with a series of products and services that help companies make clinical development decisions, inform commercial and BD&L strategy, and benchmark their programs against the competition.